Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Du Zhou

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Pathology Oncology Research : POR|December 11, 2012
Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinomaPeng Zhou, Lie-Lin Wu, Ke-Min Wu, et al.
Frontiers in Oncology|May 13, 2025
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCCYu Li, Jian-Hong Zhong, Xiao-Dong Zhu, et al.
BMC Cancer|May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter studyCheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Liver Cancer|August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter StudyBin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pathology Oncology Research : POR|December 11, 2012
Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinomaPeng Zhou, Lie-Lin Wu, Ke-Min Wu, et al.
Frontiers in Oncology|May 13, 2025
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCCYu Li, Jian-Hong Zhong, Xiao-Dong Zhu, et al.
BMC Cancer|May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter studyCheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Liver Cancer|August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter StudyBin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Pageof 2